Jefferies Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
34,615
+15,131
| +78% | +$6.74M | 0.13% | 76 |
|
|
2025
Q1 | $9.45M | Buy |
19,484
+5,500
| +39% | +$2.67M | 0.08% | 113 |
|
|
2024
Q4 | $5.63M | Sell |
13,984
-18,659
| -57% | -$7.51M | 0.03% | 244 |
|
|
2024
Q3 | $15.2M | Sell |
32,643
-27,632
| -46% | -$12.9M | 0.11% | 65 |
|
|
2024
Q2 | $28.3M | Buy |
60,275
+3,453
| +6% | +$1.62M | 0.3% | 27 |
|
|
2024
Q1 | $23.8M | Buy |
56,822
+38,814
| +216% | +$16.2M | 0.22% | 37 |
|
|
2023
Q4 | $7.33M | Buy |
18,008
+17,707
| +5,883% | +$7.2M | 0.05% | 172 |
|
|
2023
Q3 | $105K | Sell |
301
-10,632
| -97% | -$3.7M | ﹤0.01% | 1011 |
|
|
2023
Q2 | $3.85M | Sell |
10,933
-191
| -2% | -$67.2K | 0.03% | 241 |
|
|
2023
Q1 | $3.5M | Buy |
11,124
+3,636
| +49% | +$1.15M | 0.03% | 249 |
|
|
2022
Q4 | $2.16M | Buy |
+7,488
| New | +$2.16M | 0.02% | 346 |
|
|
2016
Q2 | – | Sell |
-3,300
| Closed | -$262K | – | 71 |
|
|
2016
Q1 | $262K | Buy |
+3,300
| New | +$262K | 0.04% | 30 |
|